Wiwat Peerapatanapokin
Overview
Explore the profile of Wiwat Peerapatanapokin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown T, Peerapatanapokin W, Siripong N, Puckett R
J Acquir Immune Defic Syndr
. 2024 Jan;
95(1S):e13-e23.
PMID: 38180846
Background: Thirteen Asian countries use the AIDS Epidemic Model (AEM) as their HIV model of choice. This article describes AEM, its inputs, and its application to national modeling. Setting: AEM...
2.
Silhol R, Anderson R, Stevens O, Stannah J, Booton R, Baral S, et al.
J Acquir Immune Defic Syndr
. 2024 Jan;
95(1S):e59-e69.
PMID: 38180739
Background: Key populations (KPs), including female sex workers (FSWs), gay men and other men who have sex with men (MSM), people who inject drugs (PWID), and transgender women (TGW) experience...
3.
Brown T, Peerapatanapokin W
Curr Opin HIV AIDS
. 2019 Aug;
14(5):337-353.
PMID: 31368909
Purpose Of Review: To explore the comparative importance of HIV infections among key populations and their intimate partners as HIV epidemics evolve, and to review implications for guiding responses. Recent...
4.
Stover J, Brown T, Puckett R, Peerapatanapokin W
AIDS
. 2017 Mar;
31 Suppl 1:S5-S11.
PMID: 28296796
Background: The Spectrum model is used by national programs and UNAIDS to prepare annual estimates of the status of the HIV epidemic in 160 countries. The model and assumptions are...
5.
Siraprapasiri T, Ongwangdee S, Benjarattanaporn P, Peerapatanapokin W, Sharma M
J Virus Erad
. 2017 Mar;
2(Suppl 4):7-14.
PMID: 28275444
Introduction: Thailand has been heralded as a global leader in HIV prevention and treatment, and its experience with the HIV/AIDS epidemic holds valuable lessons for public health. This paper documents...
6.
Leelahavarong P, Teerawattananon Y, Werayingyong P, Akaleephan C, Premsri N, Namwat C, et al.
BMC Public Health
. 2011 Jul;
11:534.
PMID: 21729309
Background: This study aims to determine the maximum price at which HIV vaccination is cost-effective in the Thai healthcare setting. It also aims to identify the relative importance of vaccine...
7.
Park L, Siraprapasiri T, Peerapatanapokin W, Manne J, Niccolai L, Kunanusont C
J Acquir Immune Defic Syndr
. 2010 Apr;
54(4):430-6.
PMID: 20418773
Background: Analysis of HIV transmission rates has provided insight into the impacts of HIV-related prevention programming and policies in the United States by providing timely information beyond incidence or prevalence...
8.
Over M, Revenga A, Masaki E, Peerapatanapokin W, Gold J, Tangcharoensathien V, et al.
AIDS
. 2007 Sep;
21 Suppl 4:S105-16.
PMID: 17620745
Introduction: The speed with which Thailand has scaled up public provision of antiretroviral therapy (ART) has been unprecedented, with more than 80 000 individuals on treatment at the end of...